eF-site ID 1dif-AB
PDB Code 1dif
Chain A, B

click to enlarge
Title HIV-1 PROTEASE IN COMPLEX WITH A DIFLUOROKETONE CONTAINING INHIBITOR A79285
Classification ASPARTIC PROTEINASE
Compound HIV-1 PROTEASE
Source Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1) (POL_HV1BR)
Sequence A:  PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPG
RWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF
B:  PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPG
RWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF
Description (1)  HIV-1 PROTEASE, BETA-MERCAPTOETHANOL, N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE


Functional site

1) chain A
residue 8
type
ligand
sequence R
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

2) chain A
residue 25
type
ligand
sequence D
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

3) chain A
residue 27
type
ligand
sequence G
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

4) chain A
residue 28
type
ligand
sequence A
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

5) chain A
residue 29
type
ligand
sequence D
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

6) chain A
residue 48
type
ligand
sequence G
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

7) chain A
residue 49
type
ligand
sequence G
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

8) chain A
residue 50
type
ligand
sequence I
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

9) chain A
residue 82
type
ligand
sequence V
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

10) chain A
residue 84
type
ligand
sequence I
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

11) chain B
residue 8
type
ligand
sequence R
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

12) chain B
residue 25
type
ligand
sequence D
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

13) chain B
residue 27
type
ligand
sequence G
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

14) chain B
residue 28
type
ligand
sequence A
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

15) chain B
residue 29
type
ligand
sequence D
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

16) chain B
residue 48
type
ligand
sequence G
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

17) chain B
residue 49
type
ligand
sequence G
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

18) chain B
residue 50
type
ligand
sequence I
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

19) chain B
residue 84
type
ligand
sequence I
description BINDING SITE FOR RESIDUE A85 B 101
source : AC1

20) chain A
residue 60-61
type SITE
ligand
sequence DQ
description Cleavage; by viral protease (By similarity).
source Swiss-Prot : SWS_FT_FI9

21) chain B
residue 60-61
type SITE
ligand
sequence DQ
description Cleavage; by viral protease (By similarity).
source Swiss-Prot : SWS_FT_FI19

22) chain A
residue 22-33
type prosite
ligand
sequence ALLDTGADDTVL
description Eukaryotic and viral aspartyl proteases active site. [LIVMFGAC]-[LIVMTADN]-[LIVFSA]-D-[ST]-G-[STAV]-[STAPDENQ]-{GQ}
source prosite : PS00141

23) chain B
residue 22-33
type prosite
ligand
sequence ALLDTGADDTVL
description Eukaryotic and viral aspartyl proteases active site. [LIVMFGAC]-[LIVMTADN]-[LIVFSA]-D-[ST]-G-[STAV]-[STAPDENQ]-{GQ}
source prosite : PS00141

24) chain A
residue 1
type binding
ligand BME: BETA-MERCAPTOETHANOL
sequence P
description BETA-MERCAPTOETHANOL binding site
source pdb_hetatom : BME_1dif_A_100

25) chain A
residue 11-12
type binding
ligand BME: BETA-MERCAPTOETHANOL
sequence VT
description BETA-MERCAPTOETHANOL binding site
source pdb_hetatom : BME_1dif_A_100

26) chain A
residue 67
type binding
ligand BME: BETA-MERCAPTOETHANOL
sequence C
description BETA-MERCAPTOETHANOL binding site
source pdb_hetatom : BME_1dif_A_100

27) chain A
residue 8-10
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence RPL
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

28) chain A
residue 23
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence L
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

29) chain A
residue 25
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence D
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

30) chain A
residue 27-30
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence GADD
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

31) chain A
residue 32
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence V
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

32) chain A
residue 47-50
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence IGGI
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

33) chain A
residue 76
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence L
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

34) chain A
residue 80-82
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence TPV
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

35) chain A
residue 84
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence I
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

36) chain A
residue 87
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence R
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

37) chain B
residue 8-10
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence RPL
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

38) chain B
residue 23
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence L
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

39) chain B
residue 25
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence D
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

40) chain B
residue 27-30
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence GADD
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

41) chain B
residue 32
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence V
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

42) chain B
residue 47-50
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence IGGI
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

43) chain B
residue 76
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence L
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

44) chain B
residue 80-82
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence TPV
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

45) chain B
residue 84
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence I
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

46) chain B
residue 87
type binding
ligand A85: N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
sequence R
description N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE binding site
source pdb_hetatom : A85_1dif_B_101

47) chain A
residue 99
type binding
ligand BME: BETA-MERCAPTOETHANOL
sequence F
description BETA-MERCAPTOETHANOL binding site
source pdb_hetatom : BME_1dif_B_100

48) chain B
residue 1
type binding
ligand BME: BETA-MERCAPTOETHANOL
sequence P
description BETA-MERCAPTOETHANOL binding site
source pdb_hetatom : BME_1dif_B_100

49) chain B
residue 3
type binding
ligand BME: BETA-MERCAPTOETHANOL
sequence I
description BETA-MERCAPTOETHANOL binding site
source pdb_hetatom : BME_1dif_B_100

50) chain B
residue 11-12
type binding
ligand BME: BETA-MERCAPTOETHANOL
sequence VT
description BETA-MERCAPTOETHANOL binding site
source pdb_hetatom : BME_1dif_B_100

51) chain B
residue 67
type binding
ligand BME: BETA-MERCAPTOETHANOL
sequence C
description BETA-MERCAPTOETHANOL binding site
source pdb_hetatom : BME_1dif_B_100

52) chain A
residue 25
type catalytic
ligand
sequence D
description Annotated By Reference To The Literature 1a30
source CSA : CSA1

53) chain A
residue 26
type catalytic
ligand
sequence T
description Annotated By Reference To The Literature 1a30
source CSA : CSA1

54) chain B
residue 25
type catalytic
ligand
sequence D
description Annotated By Reference To The Literature 1a30
source CSA : CSA1

55) chain B
residue 26
type catalytic
ligand
sequence T
description Annotated By Reference To The Literature 1a30
source CSA : CSA1

56) chain A
residue 25
type catalytic
ligand
sequence D
description Annotated By Reference To The Literature 1a30
source CSA : CSA2

57) chain B
residue 25
type catalytic
ligand
sequence D
description Annotated By Reference To The Literature 1a30
source CSA : CSA2


Display surface

Download
Links